Literature DB >> 2816856

Circumstances surrounding the deaths of children due to asthma. A case-control study.

B D Miller1, R C Strunk.   

Abstract

Features of the courses in 12 children who died of an acute attack of asthma were compared with those in 12 children of comparable age and sex who had a life-threatening attack of asthma but survived. Information obtained by structured interviews with the families and physicians and from the medical records was used to characterize (1) the patient, family, severity, and treatment of asthma primarily in the 6 months before the attack and (2) medical circumstances and patient characteristics present on the day of and/or during the acute episode. Patients in the study (mean age, 14.1 years) and controls (mean age, 13.8 years) were in early to late adolescence, had similar long-term medication use histories and an overall rating of the severity of asthma. For the analysis of the information concerning the 6 months before the attacks, the study patients had a greater frequency of respiratory failure requiring intubation, a decrease in steroid use in the month before the attack, history of family disturbance, abnormal reaction to separation or loss, and expressed hopelessness and despair. For the period more immediately surrounding the acute attack, study patients more often had attacks starting during sleep, but less frequently experienced vomiting during the course of the attacks. Treatment of the attack by the parents was poor (primarily because of delays) in 7 of the 12 children who died, but was also a factor in 6 of the 12 controls. Our data suggest that certain characteristics of asthmatic children may place them at greater risk for death due to their asthma. In addition, we postulate that there may be inherent differences in the mechanisms of the acute attacks between the children who died and those who survived.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2816856     DOI: 10.1001/archpedi.1989.02150230052022

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  10 in total

1.  The public health implications of maternal care trade-offs.

Authors:  A Magdalena Hurtado; Carol A Lambourne; Kim R Hill; Karen Kessler
Journal:  Hum Nat       Date:  2006-06

2.  Determinants of management errors in acute severe asthma.

Authors:  J Kolbe; M Vamos; W Fergusson; G Elkind
Journal:  Thorax       Date:  1998-01       Impact factor: 9.139

Review 3.  Psychosocial factors and behavioral medicine interventions in asthma.

Authors:  Thomas Ritz; Alicia E Meuret; Ana F Trueba; Anja Fritzsche; Andreas von Leupoldt
Journal:  J Consult Clin Psychol       Date:  2012-10-01

4.  Case-control study of severe life threatening asthma (SLTA) in adults: psychological factors.

Authors:  J Kolbe; W Fergusson; M Vamos; J Garrett
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

5.  Case-control study of severe life threatening asthma (SLTA) in adults: demographics, health care, and management of the acute attack.

Authors:  J Kolbe; W Fergusson; M Vamos; J Garrett
Journal:  Thorax       Date:  2000-12       Impact factor: 9.139

6.  Comorbidity between asthma attacks and internalizing disorders among Puerto Rican children at one-year follow-up.

Authors:  Jonathan M Feldman; Alexander N Ortega; Elizabeth L McQuaid; Glorisa Canino
Journal:  Psychosomatics       Date:  2006 Jul-Aug       Impact factor: 2.386

7.  Fatal asthma or anaphylaxis?

Authors:  J Rainbow; G J Browne
Journal:  Emerg Med J       Date:  2002-09       Impact factor: 2.740

8.  Psychological factors in asthma.

Authors:  Ryan J Van Lieshout; Glenda Macqueen
Journal:  Allergy Asthma Clin Immunol       Date:  2008-03-15       Impact factor: 3.406

Review 9.  The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.

Authors:  M R Sears; D R Taylor
Journal:  Drug Saf       Date:  1994-10       Impact factor: 5.606

10.  Clinical and molecular aspects of glucocorticoid resistant asthma.

Authors:  Chris J Corrigan; Tuck-Kay Loke
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.